NCT06122025

Evaluation of Patient Access to People With Cystic Fibrosis (CF) and Healthcare Professionals

Completed NA Last updated 8 November 2023

What this trial tests

NA trial testing Patient Access in Cystic Fibrosis in 102 participants. Completed in 7 October 2019.

Timeline

11 December 2017

Primary endpoint
7 October 2019

7 October 2019

Quick facts

Lead sponsor	The Leeds Teaching Hospitals NHS Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	102
Start date	11 December 2017
Primary completion	7 October 2019
Estimated completion	7 October 2019
Sites	1 location across United Kingdom

Drugs / interventions tested

• Patient Access

Conditions studied

• Cystic Fibrosis — all drugs for Cystic Fibrosis →

Sponsor

The Leeds Teaching Hospitals NHS Trust

Who can join

17 and older, any sex, with Cystic Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cystic fibrosis (CF) is one of the most common inherited conditions in the United Kingdom (UK). There are 10,810 people living with CF in the UK, with median predicted survival now 47 years old. People with CF have multiple medical treatments to do on a daily basis, and the treatment burden is increasing. Adherence to treatment plays an important role in health outcomes and survival in CF.

Online access to their own health care records gives people an increased control over their own health, greater understanding of their conditions and has a potential to improve adherence to care plans and medications. Whilst implementation of electronic records is established in primary care, there has been a much poorer roll out of electronic care records in the secondary care system.

Leeds Teaching Hospitals CF Unit is a regional centre with around 650 adult and paediatric registered patients. Handwritten and typed paper records of patients under the care of the CF unit in Leeds were replaced in 2007 by electronic healthcare records (EHR; EMIS®). Patients view and obtain graphical feedback at each clinic visit including trends in parameters such as lung function, weight and inflammatory markers. In partnership with Egton Medical Information Systems (EMIS) web (EMIS®), a modification allowing secondary care access to patient records has been developed.

In a structured programme of research, the Leeds Adult CF Unit have firstly evaluated the implementation of the EHR in secondary care in terms of service delivery and cost improvement. In the second phase, the investigators sought patient feedback regarding which aspects of their EHR people with CF wish to access, and their priorities for development. This has informed the third phase in which the aim is to explore the impact of patient access to their EHR.

The aims of the trial are 1. To evaluate the feasibility, benefits and acceptability to patients and health care professionals of providing secure access of linked secondary care and patient's Personal Health Records in CF, and 2. To explore technological usability, future functionality and the impact of the shared records on clinical resources, communication and patient and health care professional satisfaction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Providing Mobile Patient Access to Their Electronic Secondary Care Patient Record in Adults With Cystic Fibrosis: Results of a Prospective, Parallel, Randomized Open-Pilot Quantitative Study.
   Chadwick HK, Sawant A, White H, Gillgrass L, et al · · 2025 · PMID 41447265 · DOI 10.2196/69747